Latest news about Manipal Health Enterprises
Manipal Health co-CEO targets volume growth, capacity expansion, and deleveraging
Manipal Health Enterprises
738.95
+17.40(+2.41%)
Company Performance:
View Company Insights1D+2.41%
1M+2.22%
6M+25.25%
1Y+25.25%
5Y+25.25%
More news about Manipal Health Enterprises
21Aug 26
Manipal Health board approves Q1FY27 unaudited standalone, consolidated results
Revenue grew 38.1% YoY to ₹3,091 crore in Q1FY27. Board approved unaudited standalone and consolidated results on August 20, 2026. Adjusted PAT grew 30.9% YoY after excluding acquisition-related interest costs. Occupancy rates improved by 290 bps to 65.0%. CONGO-R specialty gross inpatient revenue grew 45% YoY.
10Aug 26
Manipal Health Enterprises pledges 6.31 crore shares to secure NCDs
Manipal Health Enterprises Limited disclosed a pledge of 6.31 crore shares by promoter entities MEMG India and MEMGIPL to secure INR 9,420 crore in NCDs. The encumbrance affects 4.80% of total share capital, with an additional 23.26% subject to covenants, bringing total encumbered shares to 28.06%. Vistra ITCL serves as the common security trustee.
10Aug 26
Manipal Health Enterprises promoters encumber 21.78% stake for term loan
Deutsche Bank AG disclosed that 286,443,818 shares of Manipal Health Enterprises Limited, held by promoter entities Manipal Global Health Services, Cypress Holdings, and MRMSI, have been encumbered. This represents 21.78% of the issued capital and 21.50% on a diluted basis. The encumbrance serves as security for a term loan facility, involving indirect charges created by parent companies MEMG International Ltd and Manipal Global Health Services in May and July 2025.
10Aug 26
Manipal Health Enterprises discloses 8.86% stake encumbrance
Manipal Health Enterprises Limited disclosed an encumbrance over 116.6 million shares (8.86% stake) via non-disposal undertaking. Axis Trustee Services Limited acts as onshore security agent for a term loan facility secured by Manipal Global Health Services and Cypress Holdings. The shares are held in trust for lenders but carry no beneficial interest for the agent.
06Aug 26
Manipal Health Enterprises appoints Sathish K R as Compliance Officer
Manipal Health Enterprises Limited has confirmed Sathish K R as its Compliance Officer since November 25, 2025. The disclosure, filed on August 5, 2026, aligns with SEBI LODR Regulations and highlights his dual role as Company Secretary and General Counsel, ensuring robust governance continuity.
05Aug 26
Manipal Health Enterprises authorizes KMPs to decide materiality
Manipal Health Enterprises Limited has empowered its Key Managerial Personnel, including MD Dilip Jose and CFO Sameer Agarwal, to determine the materiality of events for regulatory disclosures. This authorization under SEBI Listing Regulations aims to streamline compliance and ensure timely investor communication. The details were filed with BSE and NSE on August 5, 2026.
05Aug 26
Manipal Health confirms KFin as Registrar and Share Transfer Agent
Manipal Health Enterprises Limited appointed KFin Technologies Limited as its Registrar and Share Transfer Agent effective February 13, 2025. The move complies with SEBI LODR Regulation 7(1). The filing was submitted on August 5, 2026.
05Aug 26
Manipal Health Enterprises adopts SEBI fair disclosure code for UPSI
Manipal Health Enterprises Limited has implemented a comprehensive Code of Practices for fair disclosure of Unpublished Price Sensitive Information under SEBI PIT Regulations. The framework assigns responsibilities to the CIRO and Compliance Officer to ensure prompt, uniform dissemination of material data. It includes strict protocols for analyst interactions, handling market rumors, and sharing information for legitimate business purposes, with a mandatory eight-year digital record retention. The policy takes effect upon Board approval of the Draft Red Herring Prospectus.
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
